UTHR
HEALTHCAREUnited Therapeutics Corp
$596.76+24.56 (+4.29%)PRE
Live · NASDAQ · May 9, Close
AI Insight
What's Moving UTHR Today?
No stock-specific AI insight has been generated for UTHR yet. Check back soon — insights are generated from recent news analysis.
52-Week Range
$272.12$609.35
$596.76
Fundamentals
Market Cap$24.2B
P/E Ratio21.0
EPS$27.06
Dividend Yield—
Dividend / Share—
ROE0.2%
Profit Margin0.4%
Debt / Equity—
Trading
Volume660K
Avg Volume (10D)—
Shares Outstanding42.4M
UTHR News
23 articles- MannKind (MNKD) Is Up 25.4% After Mixed Q1 Results and Expanded United Therapeutics Partnership – What's ChangedYahoo Finance·May 8, 2026
- United Therapeutics Growth Outlook Remains Supported by Tyvaso, Ralinepag, RBC SaysYahoo Finance·May 7, 2026
- UTHR Q1 Earnings Miss Estimates, Shares Jump on Strong OutlookYahoo Finance·May 7, 2026
- Oracle upgraded, Planet Fitness downgraded: Wall Street's top analyst callsYahoo Finance·May 7, 2026
- Here Are Thursday’s Top Wall Street Analyst Research Calls: Alcoa, Chiron Real Estate, Clear Secure, Fortinet, Fresh Pet, Kennametal, Oracle, PayPal, United Therapeutics, and More247 Wall St·May 7, 2026
- United Therapeutics Q1 Earnings Call HighlightsMarketbeat·May 7, 2026
- MannKind Q1 Earnings Call HighlightsMarketbeat·May 7, 2026
- MannKind Corporation Q1 2026 Earnings Call SummaryMoby·May 7, 2026
- MannKind (MNKD) Q1 2026 Earnings TranscriptMotley Fool·May 6, 2026
- United Therapeutics Corporation Q1 2026 Earnings Call SummaryMoby·May 6, 2026
- MannKind Reports First Quarter 2026 Financial Results and Provides Business UpdateYahoo Finance·May 6, 2026
- United Therapeutics (UTHR) Misses Q1 Earnings and Revenue EstimatesYahoo Finance·May 6, 2026
- United Therapeutics (NASDAQ:UTHR) Reports Sales Below Analyst Estimates In Q1 CY2026 EarningsYahoo Finance·May 6, 2026
- MannKind Announces Ralinepag Dry Powder Inhalation (DPI) Program to be Pursued for Pulmonary Hypertension and Fibrotic Lung DiseasesYahoo Finance·May 6, 2026
- United Therapeutics Corporation Reports First Quarter 2026 Financial ResultsYahoo Finance·May 6, 2026
- Ahead of United Therapeutics (UTHR) Q1 Earnings: Get Ready With Wall Street Estimates for Key MetricsYahoo Finance·May 5, 2026
- ImmunityBio to Report Q1 Earnings: What's in the Cards?Yahoo Finance·May 4, 2026
- Will United Therapeutics (UTHR) Beat Estimates Again in Its Next Earnings Report?Yahoo Finance·May 4, 2026
- Assessing United Therapeutics (UTHR) Valuation After A Strong Multi Year Share Price RunYahoo Finance·May 3, 2026
- Madrigal (MDGL) Expected to Beat Earnings Estimates: What to Know Ahead of Q1 ReleaseYahoo Finance·Apr 29, 2026
- Interstitial Lung Disease Market to Witness Accelerated Growth at a CAGR of 8.7% During the Forecast Period (2026–2036) Due to the Launch of Emerging Therapies | DelveInsightGlobeNewswire Inc.·Apr 8, 2026
- Stocks Rise As Powell's Remarks Cool Rate Fears: What's Moving Markets Monday?Benzinga·Mar 30, 2026
- Why Is United Therapeutics Stock Soaring Monday?Benzinga·Mar 30, 2026
All 23 articles loaded
Price Data
Open$569.00
Previous Close$572.20
Day High$573.30
Day Low$565.56
52 Week High$609.35
52 Week Low$272.12
52-Week Range
$272.12$609.35
$596.76
Fundamentals
Market Cap$24.2B
P/E Ratio21.0
EPS$27.06
Dividend Yield—
Dividend / Share—
ROE0.2%
Profit Margin0.4%
Debt / Equity—
Trading
Volume660K
Avg Volume (10D)—
Shares Outstanding42.4M
About United Therapeutics Corp
United Therapeutics Corporation, a biotechnology company, is dedicated to the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. The company is headquartered in Silver Spring, Maryland.
HEALTHCAREDRUG MANUFACTURERS - SPECIALTY & GENERIC
Company Details
Security TypeStock
ExchangeNASDAQ
CurrencyUSD
Round Lot—
SICDRUG MANUFACTURERS - SPECIALTY & GENERIC
CIK—
Composite FIGI—
Share Class FIGI—